The roles of nausea and vomiting in COVID-19: did we miss something?
J Microbiol Immunol Infect
; 54(4): 541-546, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-866907
ABSTRACT
The Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an international public health emergency. Although respiratory symptoms predominate the clinical manifestations of COVID-19, gastrointestinal symptoms have been observed in a subset of patients. Notably, some patients have nausea/vomiting as the first clinical manifestation of COVID-19, which is often overlooked by people. It is now clear that not only the lungs, the gastrointestinal tract could also be attacked by SARS-CoV-2. Its host receptor angiotensin-converting enzyme 2 (ACE2), which acts as a gateway to infection, has been found to be highly expressed in the gastrointestinal epithelium and may lead to the development of nausea/vomiting. Raise awareness of these symptoms and take timely intervention would help people combat the pandemic. This review discussed epidemiology, mechanisms, management, and prevention of COVID-19 related nausea and vomiting.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vomiting
/
SARS-CoV-2
/
COVID-19
/
Nausea
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Microbiol Immunol Infect
Journal subject:
Allergy and Immunology
/
Microbiology
Year:
2021
Document Type:
Article
Affiliation country:
J.jmii.2020.10.005
Similar
MEDLINE
...
LILACS
LIS